Online citations, reference lists, and bibliographies.
← Back to Search

Preparation, Characterization And In Vivo Evaluation Of A Combination Delivery System Based On Hyaluronic Acid/jeffamine Hydrogel Loaded With PHBV/PLGA Blend Nanoparticles For Prolonged Delivery Of Teriparatide

N. B. Javan, H. Montazeri, Leila Rezaie Shirmard, N. J. Omid, Ghullam Reza Barbari, M. Amini, M. Ghahremani, M. Rafiee-Tehrani, F. Dorkoosh
Published 2017 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
ABSTRACT In the current study, biodegradable PHBV/PLGA blend nanoparticles (NPs) containing Teriparatide were loaded in hyaluronic acid/jeffamine (HA‐JEF ED‐600) hydrogel to prepare a combination delivery system (CDS) for prolonged delivery of Teriparatide. The principal purpose of the present study was to formulate an effective and prolonged Teriparatide delivery system in order to reduce the frequency of injection and thus enhance patient's compliance. Morphological properties, swelling behaviour, crosslinking efficiency and rheological characterization of HA‐JEF ED‐600 hydrogel were evaluated. The CDS was acquired by adding PHBV/PLGA NPs to HA‐JEF ED‐600 hydrogel simultaneously with crosslinking reaction. The percentage of NPs incorporation within the hydrogel as well as the loading capacity and morphology of Teriparatide loaded CDS were examined. Intrinsic fluorescence and circular dichroism spectroscopy proved that Teriparatide remains stable after processing. The release profile represented 63% Teriparatide release from CDS within 50 days with lower burst release compared to NPs and hydrogel. MTT assay was conducted by using NIH3T3 cell line and no sign of reduction in cell viability was observed. Based on Miller and Tainter method, LD50 of Teriparatide loaded CDS was 131.8 mg/kg. In vivo studies demonstrated that Teriparatide loaded CDS could effectively increase serum calcium level after subcutaneous injection in mice. Favourable results in the current study introduced CDS as a promising candidate for controlled delivery of Teriparatide and pave the way for future investigations in the field of designing prolonged delivery systems for other peptides and proteins. Graphical abstract Figure. No Caption available.
This paper references
10.1166/JNN.2009.217
A novel composite drug delivery system: honokiol nanoparticles in thermosensitive hydrogel based on chitosan.
X. Li (2009)
10.5099/AJ120100070
A Simple Parallel Plate Flow Chamber to Study Effects of Shear Stress on Endothelial Cells
H. Kaur (2012)
10.1002/JBM.A.30759
Selectively crosslinked hyaluronic acid hydrogels for sustained release formulation of erythropoietin.
K. Motokawa (2006)
10.1016/j.jpha.2011.12.001
Development and validation of RP-HPLC and RP-UPLC methods for quantification of parathyroid hormones (1-34) in medicinal product formulated with meta-cresol
Shaligram S. Rane (2012)
10.1185/030079906X100276
Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis
J. Iwamoto (2006)
10.1002/jps.23974
Protein nanoparticles for intracellular delivery of therapeutic enzymes.
L. H. Estrada (2014)
10.1016/j.bone.2014.07.014
Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis.
E. Eriksen (2014)
10.1093/CLINCHEM/25.8.1519
Modification of the o-cresolphthalein complexone method for determining calcium.
S. Cohen (1979)
DETERMINATION OF MEDIAN LETHAL DOSE OF TRIAZOPHOS (TZ) WITH DMSO IN WISTAR RAT
M. Chandra (2014)
10.1016/S0168-3659(03)00194-9
Biodegradable microspheres for protein delivery.
V. Sinha (2003)
10.1016/J.COLSURFB.2007.04.009
Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release.
Quan Gan (2007)
10.1016/j.colsurfb.2010.09.012
Poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanosphere. Part 2: Simultaneous release of a drug and a prodrug (clindamycin and clindamycin phosphate).
M. Vukomanović (2011)
10.2147/IJN.S72590
In vitro cytotoxicity analysis of doxorubicin-loaded/superparamagnetic iron oxide colloidal nanoassemblies on MCF7 and NIH3T3 cell lines
K. Tománková (2015)
10.1016/j.jconrel.2012.03.024
Enhanced neurotrophin-3 bioactivity and release from a nanoparticle-loaded composite hydrogel.
Jason C. Stanwick (2012)
10.1517/17425247.2.1.29
Commercial challenges of protein drug delivery
L. Brown (2005)
10.1016/j.carbpol.2012.02.062
The effect of nanoparticles on gastrointestinal release from modified κ-carrageenan nanocomposite hydrogels.
H. Hezaveh (2012)
10.1016/j.ijpharm.2012.08.006
Development and evaluation of sustained-release clonidine-loaded PLGA microparticles.
A. Gaignaux (2012)
10.1016/j.jconrel.2008.11.028
An injectable hyaluronic acid-tyramine hydrogel system for protein delivery.
F. Lee (2009)
10.1056/NEJM200105103441904
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
R. Neer (2001)
10.1016/j.carbpol.2013.04.090
Hyaluronan derivatives: Alkyl chain length boosts viscoelastic behavior to depolymerization.
M. Pavan (2013)
10.1016/j.ijpharm.2009.09.046
PLGA/PVA hydrogel composites for long-term inflammation control following s.c. implantation.
U. Bhardwaj (2010)
10.1080/02652048.2016.1208296
Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide
N. B. Javan (2016)
10.1016/j.cis.2013.12.008
Core/shell nanoparticles in biomedical applications.
Krishnendu Chatterjee (2014)
10.1016/j.biomaterials.2011.10.072
A rapid-acting, long-acting insulin formulation based on a phospholipid complex loaded PHBHHx nanoparticles.
Qiang Peng (2012)
10.1016/j.carbpol.2012.08.004
κ-Carrageenan hydrogel nanocomposites with release behavior mediated by morphological distinct Au nanofillers.
A. M. Salgueiro (2013)
10.1002/jbm.a.31978
In vitro characterization of hepatocyte growth factor release from PHBV/PLGA microsphere scaffold.
X. H. Zhu (2009)
10.1016/j.colsurfb.2012.02.030
Preparation and characterization of rifampicin-PLGA microspheres/sodium alginate in situ gel combination delivery system.
Chunhui Hu (2012)
10.1016/j.jconrel.2009.09.010
Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives.
E. J. Oh (2010)
10.1016/j.biomaterials.2011.05.044
Network connectivity, mechanical properties and cell adhesion for hyaluronic acid/PEG hydrogels.
S. Ouasti (2011)
10.4314/TJPR.V11I3.6
In-vitro Release Study of Carvedilol Phosphate Matrix Tablets Prepared with Hydroxypropyl Methylcellulose
Shimul Halder (2012)
10.1016/j.ejpb.2008.04.025
A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties.
L. Mayol (2008)
10.1016/J.JCONREL.2006.03.017
PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery.
N. Csaba (2006)
10.1166/JBN.2012.1367
Synthesis, characterization and preliminary in vitro evaluation of PTH 1-34 loaded chitosan nanoparticles for osteoporosis.
D. Narayanan (2012)
10.1166/ASL.2014.5531
Poly(lactide-co-glycolide) Nanoparticles for an Extended Delivery of Bevacizumab to Retina: Formulation and In Vitro Characterization
J. Pandit (2014)
10.1016/j.matbio.2009.05.001
Hyaluronan concentration within a 3D collagen matrix modulates matrix viscoelasticity, but not fibroblast response.
S. Kreger (2009)
10.1016/j.actbio.2012.09.034
Injectable and biodegradable thermosensitive hydrogels loaded with PHBHHx nanoparticles for the sustained and controlled release of insulin.
Q. Peng (2013)
10.3305/nh.2013.28.4.6461
Cytotoxicity of Agaricus sylvaticus in non-tumor cells (NIH/3T3) and tumor (OSCC-3) using tetrazolium (MTT) assay.
J. V. C. Orsine (2013)
10.1016/j.ijpharm.2010.12.020
Modeling of drug release from bulk-degrading polymers.
L. L. Lao (2011)
10.1016/j.biomaterials.2013.02.034
Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells.
C. Vilos (2013)
10.2217/NNM.13.159
Hydrogel nanoparticles for drug delivery.
M. Dalby (2013)
10.1007/BF02980037
Control of encapsulation efficiency and initial burst in polymeric microparticle systems
Yoon Yeo (2004)
10.1517/17425247.5.6.615
Analysis of initial burst in PLGA microparticles
S. Allison (2008)
10.1016/j.carbpol.2014.08.097
Precise tailoring of tyramine-based hyaluronan hydrogel properties using DMTMM conjugation.
C. Loebel (2015)
10.1016/S0142-9612(03)00528-3
The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres.
G. Wei (2004)
10.1080/02652040500098994
Optimizing double emulsion process to decrease the burst release of protein from biodegradable polymer microspheres
J. Zhang (2005)
10.1016/J.CARBPOL.2007.04.002
Mechanical properties and degradation behaviors of hyaluronic acid hydrogels cross-linked at various cross-linking densities
O. Jeon (2007)
10.1016/J.BIOMATERIALS.2006.11.050
Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells.
J. Kim (2007)
10.1016/j.jconrel.2008.06.011
Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregation.
Y. Geng (2008)
10.1007/s11657-013-0136-1
Osteoporosis in the European Union: medical management, epidemiology and economic burden
E. Hernlund (2013)
10.1359/JBMR.041114
Drugs Used to Treat Osteoporosis: The Critical Need for a Uniform Nomenclature Based on Their Action on Bone Remodeling
B. Riggs (2005)
10.1007/s11095-011-0452-3
Combination of Hyaluronic Acid Hydrogel Scaffold and PLGA Microspheres for Supporting Survival of Neural Stem Cells
Y. Wang (2011)
10.1016/J.JCONREL.2007.04.015
Non-viral vector delivery from PEG-hyaluronic acid hydrogels.
J. A. Wieland (2007)
10.1517/17425247.5.6.615
Analysis of initial burst in PLGA microparticles.
S. Allison (2008)
10.1016/j.actbio.2012.05.027
Tunable hydrogel-microsphere composites that modulate local inflammation and collagen bulking.
Elena Tous (2012)
Protein secondary structure and circular dichroism: a practical guide. Proteins: Structure, Function, and Bioinformatics
W. Johnson (1990)
10.1016/S0006-3495(01)76183-8
Mechanisms of tryptophan fluorescence shifts in proteins.
J. Vivian (2001)
10.1016/J.BIOMATERIALS.2004.02.018
Characterization of protein release from photocrosslinkable hyaluronic acid-polyethylene glycol hydrogel tissue engineering scaffolds.
J. Leach (2005)
Preparation, characterization and optimization of glipizide controlled release nanoparticles
J. Emami (2014)
10.3181/00379727-57-14776
Estimation of the ED50 and Its Error by Means of Logarithmic-Probit Graph Paper.∗
L. Miller (1944)
10.1358/DOT.2004.40.11.872582
Teriparatide: A bone formation treatment for osteoporosis.
E. Eriksen (2004)
10.1016/j.actbio.2012.03.015
Sustained release of PTH(1-34) from PLGA microspheres suppresses osteoarthritis progression in rats.
Rajalakshmanan Eswaramoorthy (2012)
10.1016/J.EJPB.2006.09.009
High throughput screening of protein formulation stability: practical considerations.
M. Capelle (2007)
10.1590/S1984-82502012000400021
Microspheres prepared with biodegradable PHBV and PLA polymers as prolonged-release system for ibuprofen: in vitro drug release and in vivo evaluation
G. Bazzo (2012)
10.1016/j.bmcl.2011.03.058
Tumor-specific hybrid polyhydroxybutyrate nanoparticle: surface modification of nanoparticle by enzymatically synthesized functional block copolymer.
J. Lee (2011)
10.1002/wnan.54
Assessing nanotoxicity in cells in vitro.
Jedd M. Hillegass (2010)
bination of hyaluronic acid hydrogel scaffold and PLGA microspheres for supporting survival of neural stem cells
Y. Wang (2011)
10.3949/ccjm.78a.11022
What is the optimal duration of bisphosphonate therapy?
S. Ott (2011)
10.1016/J.BIOMATERIALS.2004.02.067
Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern.
Tatiana Segura (2005)
10.1002/PROT.340070302
Protein secondary structure and circular dichroism: A practical guide
W. C. Johnson (1990)
10.1016/J.IJPHARM.2006.05.024
Sustained release formulation of erythropoietin using hyaluronic acid hydrogels crosslinked by Michael addition.
S. Hahn (2006)
10.2174/156720107780362339
Recent advances in protein and peptide drug delivery systems.
Dhirendra Kumar Malik (2007)
10.2147/CLEP.S40966
The clinical epidemiology of male osteoporosis: a review of the recent literature
T. Willson (2015)
10.2174/187221109787158300
Smart polymers for controlled delivery of proteins and peptides: a review of patents.
L. R. Fogueri (2009)
10.1016/j.colsurfb.2010.09.011
Poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanospheres. Part 1: A multifunctional system for controlled drug delivery.
M. Vukomanović (2011)
10.2147/MDER.S13962
Ionically cross-linked hyaluronic acid: wetting, lubrication, and viscoelasticity of a modified adhesion barrier gel
K. Vorvolakos (2011)
10.1039/c1cp20636b
Modus operandi of controlled release from mesoporous matrices: a theoretical perspective.
T. Ukmar (2011)
10.1002/bit.22361
Hydrogels as extracellular matrix mimics for 3D cell culture.
Mark W. Tibbitt (2009)
10.2225/VOL15-ISSUE4-FULLTEXT-2
Ceftiofur-loaded PHBV microparticles: A potential formulation for a long-acting antibiotic to treat animal infections
C. Vilos (2012)
10.1016/j.jconrel.2011.06.038
Understanding controlled drug release from mesoporous silicates: theory and experiment.
T. Ukmar (2011)
Effect of methionine oxidation and deletion of amino-terminal residues on the conformation of parathyroid hormone. Circular dichroism studies.
J. Zull (1990)
10.1016/J.MSEC.2009.05.015
A novel PHBV/HA microsphere releasing system loaded with alendronate
W. Huang (2009)
10.1208/s12249-011-9585-2
The Effects of Excipients and Particle Engineering on the Biophysical Stability and Aerosol Performance of Parathyroid Hormone (1-34) Prepared as a Dry Powder for Inhalation
S. Shoyele (2011)
10.1100/2012/542937
PHBV/PCL Microparticles for Controlled Release of Resveratrol: Physicochemical Characterization, Antioxidant Potential, and Effect on Hemolysis of Human Erythrocytes
Jessica Bitencourt Emilio Mendes (2012)
10.1016/j.ijpharm.2013.06.066
A new highly viscoelastic hyaluronic acid gel: rheological properties, biocompatibility and clinical investigation in esthetic and restorative surgery.
T. Iannitti (2013)
Calculation of LD50 values from the method of Miller and Tainter, 1944.
M. A. Randhawa (2009)
10.1016/j.addr.2008.08.002
Hydrogel nanoparticles in drug delivery.
M. Hamidi (2008)
10.1016/J.COLSURFA.2006.09.036
Stability and physicochemical characteristics of PLGA, PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: A comparative study
M. J. Santander-Ortega (2007)
Parathyroid hormone: synthesis, secretion, and action
E. Brown (2006)
10.1016/j.ejps.2010.09.008
PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
Yolanda Parajó (2010)
10.1016/J.IJBIOMAC.2006.09.019
Synthesis and degradation test of hyaluronic acid hydrogels.
S. Hahn (2007)
The importance of toxicity testing
D. Arome (2013)
Optimization and characterization of diclofenac sodium microspheres prepared by a modified coacervation method.
E. S. El-Leithy (2010)
10.1007/BF00332351
Significance of the LD50-test for the toxicological evaluation of chemical substances
G. Zbinden (2004)



This paper is referenced by
10.1002/app.49819
Chitosan hydrogel covalently crosslinked by gold nanoparticle: Eliminating the use of toxic crosslinkers
Fernanda Silva Tenório (2020)
High Performance Liquid Chromatography-Size Exclusion Chromatography (Hplc-Sec) As an Efficient Tool for The Quantification of Polymers
Deepak D. Kayande (2019)
10.1080/10837450.2017.1321662
Prolonged injectable formulation of Nafarelin using in situ gel combination delivery system
Behnoush Alizadeh (2018)
10.1088/2053-1591/ab42ed
Influence of CNT pre-dispersion into PHBV/CNT nanocomposites and evaluation of morphological, mechanical and crystallographic features
Thaís L. A. Montanheiro (2019)
10.1080/03639045.2020.1721524
Improving the in-vivo biological activity of fingolimod loaded PHBV nanoparticles by using hydrophobically modified alginate
Leila Rezaie Shirmard (2020)
10.1016/j.ejps.2018.12.007
Improved anti‐colorectal carcinomatosis effect of tannic acid co‐loaded with oxaliplatin in nanoparticles encapsulated in thermosensitive hydrogel
Yutao Ren (2019)
10.3390/pharmaceutics11090432
Hydrogels Based Drug Delivery Synthesis, Characterization and Administration
Anca Onaciu (2019)
10.1080/09205063.2020.1781527
A brief review concerning the latest advances in the influence of nanoparticle reinforcement into polymeric-matrix biomaterials
T. L. A. Montanheiro (2020)
10.1016/j.jddst.2020.101570
Preparation and characterization of dry powder containing sunitinib loaded PHBV nanoparticles for enhanced pulmonary delivery
Maryam Otroj (2020)
10.1016/j.msec.2019.109791
Design of polymer-based antimicrobial hydrogels through physico-chemical transition.
E. Mauri (2019)
10.1016/J.REACTFUNCTPOLYM.2017.04.016
Study the role of poly(diethyl aminoethyl methacrylate) as a modified and grafted shell for TiO2 and ZnO nanoparticles, application in flutamide delivery
A. A. Ensafi (2017)
10.1016/j.jpha.2019.01.004
Development of a fast and precise method for simultaneous quantification of the PLGA monomers lactic and glycolic acid by HPLC
Marcel Pourasghar (2019)
Semantic Scholar Logo Some data provided by SemanticScholar